(7S,9S)-7-[(3-Amino-2,3,6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-naphthacenedione-d4; [7S-[7?,9?,9(R*)]]-7-[(3-Amino-2,3,6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-5,12-naphthacenedione-d4; 13-Dihydroidarubicin-d4; 4-Demethoxydaunorubicinol-d4; Antibiotic FCE 22723-d4
Idarubicinol-d4 is a fully characterized chemical compound used as a reference standard of API Idarubicin. The standard offered is compliant with regulatory guidelines. Idarubicinol-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
